关注
Satyanarayana Thirunahari
Satyanarayana Thirunahari
Dr Reddys Laboratories Ltd
在 drreddys.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Conformational polymorphism of tolbutamide: A structural, spectroscopic, and thermodynamic characterization of Burger’s forms I–IV
S Thirunahari, S Aitipamula, PS Chow, RBH Tan
Journal of pharmaceutical sciences 99 (7), 2975-2990, 2010
852010
Simultaneous determination of several crystal structures from powder mixtures: the combination of powder X-ray diffraction, band-target entropy minimization and Rietveld methods
M Schreyer, L Guo, S Thirunahari, F Gao, M Garland
Journal of Applied Crystallography 47 (2), 659-667, 2014
752014
Quality by design (QbD)-based crystallization process development for the polymorphic drug tolbutamide
S Thirunahari, PS Chow, RBH Tan
Crystal growth & design 11 (7), 3027-3038, 2011
562011
Resolving the longstanding riddle of pH-dependent outcome of glycine polymorphic nucleation
G Han, S Thirunahari, PS Chow, RBH Tan
CrystEngComm 15 (6), 1218-1224, 2013
452013
Second harmonic generation guided Raman spectroscopy for sensitive detection of polymorph transitions
AU Chowdhury, DH Ye, Z Song, S Zhang, HG Hedderich, B Mallick, ...
Analytical chemistry 89 (11), 5958-5965, 2017
192017
Urea mediated 5-substituted-1H-tetrazole via [3+ 2] cycloaddition of nitriles and sodium azide
B Yakambram, AJ Shree, LS Reddy, T Satyanarayana, P Naveen, ...
Tetrahedron Letters 59 (5), 445-449, 2018
152018
Solid state forms of dasatinib and processes for their preparation
S Thirunahari, AA GUPTA, S Ramakrishnan, S Swapnil, R Bandichhor, ...
US Patent 10,464,933, 2019
142019
Pharmaceutical cocrystals: a perspective on development and scale-up of solution cocrystallization
A Saha, AA Ahangar, AA Dar, S Thirunahari, JV Parambil
Crystal Growth & Design 23 (11), 7558-7581, 2023
112023
Triboluminescence from Pharmaceutical Formulations (vol 90, pg 6893, 2018)
CJ Smith, SR Griffin, GS Eakins, F Deng, JK White, S Thirunahari, ...
Analytical Chemistry 90 (21), 13131-13131, 2018
32018
Triboluminescence from pharmaceutical formulations
CJ Smith, SR Griffin, GS Eakins, F Deng, JK White, S Thirunahari, ...
Analytical chemistry 90 (11), 6893-6898, 2018
32018
Polymorphic crystallization process development
S Thirunahari
Doktorska diserzacija. Indian Institute of Technology Guwahati, 2011
22011
Process for preparation of Siponimod, its salts and solid state forms thereof
S Oruganti, K Chintada, B Kandagatla, R Cheerlavancha, VK Mudapaka, ...
US Patent 11,390,583, 2022
2022
Amorphous and crystalline forms of relugolix
JA Yadav, S Oruganti, S Sen, S Thirunahari, SC Nekkanti, SP Gopi
US Patent App. 17/610,052, 2022
2022
Solid forms of encequidar mesylate and processes thereof
S Oruganti, VVVR Eda, S Sen, A Mukherjee, S Thirunahari
US Patent App. 17/442,297, 2022
2022
Solid state forms of siponimod
S Ramakrishnan, VK Mudapaka, S Thirunahari, S Rangineni
US Patent App. 17/433,073, 2022
2022
Intra-orbital fat necrosis following transcaruncular orbitotomy mimicking a surgical site infection: A case report
AG Kapoor, VS Vijitha, R Mittal, TVS Satyanarayana
Saudi Journal of Ophthalmology 35 (4), 350-352, 2021
2021
Correction to Triboluminescence from Pharmaceutical Formulations
CJ Smith, SR Griffin, GS Eakins, F Deng, JK White, S Thirunahari, ...
Analytical Chemistry 90 (21), 13131-13131, 2018
2018
系统目前无法执行此操作,请稍后再试。
文章 1–17